Substrates for peptidase S01.160: kallikrein 1
Peptide and protein substrates that are thought to be physiologically relevant are indicated by P. Peptide and protein substrates that are thought to be pathologically relevant are indicated by D. Peptide and protein substrates that are not physiologically relevant are indicated by N. Synthetic substrates are indicated by S. Click on the symbol to show only physiological, non-physiological or synthetic substrates, or here to display all substrates. How cleavage sites have been identified are indicated by the following evidence codes: NT = N-terminal sequencing, MS = mass spectroscopy, MU = mutation, CS = consensus sequence, LC = liquid chromatography. To see all annotated cleavages for a protein substrate, click on the UniProt Accession.
| Substrate | Uniprot | Residue range | Cleavage Site | Cleavage type | Evidence | P4 | P3 | P2 | P1 | P1' | P2' | P3' | P4' | Reference | CutDB | MERNUM |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Antileukoproteinase | P03973 | 26-132 | peptide-Arg45+Tyr-peptide | P | NT | Gln | Cys | Leu | Arg | Tyr | Lys | Lys | Pro | Borgoņo et al., 2007 | ||
| Bz-Arg-NHPhNO2 (BAPNA) | Bz-Arg+NHPhNO2 | S | - | - | Bz | Arg | NAN | - | - | - | Hauske et al., 2009 | |||||
| Bz-Pro-Phe-Arg-NHPhNO2 | Bz-Pro-Phe-Arg+NHPhNO2 | S | Bz | Pro | Phe | Arg | NAN | - | - | - | Chao, 2004 | |||||
| coagulation factor XII | P00748 | 20-615 | peptide-Arg362+Leu-peptide | P | Cys | Gly | Gln | Arg | Leu | Arg | Lys | Ser | Cool et al., 1985 | 18072 | ||
| Desmoglein-1 | Q02413 | 50-1049 | peptide-Lys197+Ile-peptide | P | NT | Ile | Ala | Phe | Lys | Ile | Ile | Arg | Gln | Borgoņo et al., 2007 | ||
| Desmoglein-1 | Q02413 | 50-1049 | peptide-Lys445+Asn-peptide | P | NT | Leu | Thr | Leu | Lys | Asn | Lys | Val | Thr | Borgoņo et al., 2007 | ||
| DL-Val-Leu-Arg-NHPhNO2 | DL-Val-Leu-Arg+NHPhNO2 | S | - | Val | Leu | Arg | NAN | - | - | - | Chao, 2004 | |||||
| Kallikrein-9 precursor | Q9UKQ9 | 16-250 | peptide-Arg22+Ala-peptide | P | NT | Ala | Asp | Thr | Arg | Ala | Ile | Gly | Ala | Yoon et al., 2007 | ||
| kininogen-1 | P01042 | 19-644 | peptide-Met361+Lys-peptide | P | Ile | Ser | Leu | Met | Lys | Arg | Pro | Pro | Del Nery et al., 1996 | 17292 | ||
| kininogen-1 | P01042 | 19-644 | peptide-Arg371+Ser-peptide | P | Ser | Pro | Phe | Arg | Ser | Ser | Arg | Ile | Gomes et al., 1997 | 17291 | ||
| phage display octapeptide 3R-1 | peptide-Arg4+Ser-peptide | N | Leu | Glu | Ala | Arg | Ser | Ala | Tyr | His | Li et al., 2008 | |||||
| phage display octapeptide 3R-13 | peptide-Arg4+Ser-peptide | N | Glu | Ala | Lys | Arg | Ser | Tyr | His | Ser | Li et al., 2008 | |||||
| phage display octapeptide 3R-7 | peptide-Trp4+Ser-peptide | N | Pro | Asn | Arg | Trp | Ser | Thr | Gly | Ala | Li et al., 2008 | |||||
| phage display octapeptide 4R-25 | peptide-Tyr4+Ser-peptide | N | Glu | Ala | Phe | Tyr | Ser | Gln | Arg | Phe | Li et al., 2008 | |||||
| phage display octapeptide 5R-18 | peptide-Ile4+Ser-peptide | N | Ser | Ser | Tyr | Ile | Ser | Asn | Phe | Gly | Li et al., 2008 | |||||
| phage display octapeptide 5R-4 | peptide-Arg4+Ser-peptide | N | Asn | Ala | Ala | Arg | Ser | Thr | Gly | Ala | Li et al., 2008 | |||||
| phage display octapeptide 6R-11 | peptide-Trp4+Ser-peptide | N | Ser | Ser | Glu | Trp | Ser | Met | Pro | Tyr | Li et al., 2008 | |||||
| phage display octapeptide 6R-13 | peptide-Phe4+Arg-peptide | N | Gly | Thr | Leu | Phe | Arg | Ser | Gly | Asn | Li et al., 2008 | |||||
| phage display octapeptide 6R-26 | peptide-Tyr4+Ser-peptide | N | Ala | Arg | Leu | Tyr | Ser | Arg | Gly | Ala | Li et al., 2008 | |||||
| phage display octapeptide 6R-27 | peptide-Arg4+Ser-peptide | N | Glu | Ala | Ser | Arg | Ser | Ala | Thr | Leu | Li et al., 2008 | |||||
| phage display octapeptide 6R-28 | peptide-Tyr4+Arg-peptide | N | Glu | Ala | Ser | Tyr | Arg | Arg | Lys | Gln | Li et al., 2008 | |||||
| phage display octapeptide 6R-29 | peptide-Tyr4+Arg-peptide | N | Thr | Thr | Phe | Tyr | Arg | Arg | Gly | Ala | Li et al., 2008 | |||||
| phage display octapeptide 6R-30 | peptide-Tyr4+Arg-peptide | N | Ala | Ala | Trp | Tyr | Arg | Thr | Ser | Arg | Li et al., 2008 | |||||
| phage display octapeptide 6R-44 | peptide-Tyr4+Arg-peptide | N | Ser | Phe | His | Tyr | Arg | Met | Val | Gly | Li et al., 2008 | |||||
| phage display octapeptide 6R-5 | peptide-Tyr4+Arg-peptide | N | Ala | Ser | Ser | Tyr | Arg | Thr | Ser | Arg | Li et al., 2008 | |||||
| phage display octapeptide 6R-8 | peptide-Tyr4+Ser-peptide | N | Thr | Arg | Phe | Tyr | Ser | Arg | Gly | Arg | Li et al., 2008 | |||||
| Pro-Phe-Arg-NHMec | Pro-Phe-Arg+NHMec | S | - | Pro | Phe | Arg | AMC | - | - | - | Chao, 2004 | |||||
| Proteinase-activated receptor 1 | P25116 | 38-60 | Peptide-Arg41+Ser-Peptide | N | NT | Leu | Asp | Pro | Arg | Ser | Phe | Leu | Leu | Parry et al., 1996 | ||
| SERPINA4 serine (or cysteine) proteinase inhibitor, clade A (alpha-1 antiproteinase, antitrypsin), member 4 | P29622 | 1-427 | peptide-Phe388+Ser-peptide | P | Ile | Lys | Phe | Phe | Ser | Ala | Gln | Thr | Chai et al., 1993 | 24037 | ||
| Tos-Arg-OMe (TAME) | Tos-Arg+OMe | S | - | - | Tos | Arg | OMe | - | - | - | Chao, 2004 | |||||
| Val-Leu-Arg-NHMec | Val-Leu-Arg+NHMec | S | - | Val | Leu | Arg | AMC | - | - | - | Chao, 2004 |
